Tolerance to self requires an intact regulatory T cell (T reg cell) pool that acts to limit autoimmunity and maintain homeostasis within the immune system. T reg cells develop within the thymus from CD4 + single-positive (CD4SP) thymocytes, as well as extrathymically from conventional CD4 + T cells. Neonatal thymectomy leads to autoimmunity, which illustrates the importance of maintaining proper thymic T reg cell output 1,2 . Although thymus-derived T reg cells and extrathymically derived T reg cells overlap in their functional capacity, thymus-derived T reg cells are more stable under inflammatory conditions 3 . Therefore, understanding the factors that govern T reg cell development in the thymus is important for the design of strategies to generate large, stable T reg cell populations for immunotherapy 4, 5 .
Tolerance to self requires an intact regulatory T cell (T reg cell) pool that acts to limit autoimmunity and maintain homeostasis within the immune system. T reg cells develop within the thymus from CD4 + single-positive (CD4SP) thymocytes, as well as extrathymically from conventional CD4 + T cells. Neonatal thymectomy leads to autoimmunity, which illustrates the importance of maintaining proper thymic T reg cell output 1, 2 . Although thymus-derived T reg cells and extrathymically derived T reg cells overlap in their functional capacity, thymus-derived T reg cells are more stable under inflammatory conditions 3 . Therefore, understanding the factors that govern T reg cell development in the thymus is important for the design of strategies to generate large, stable T reg cell populations for immunotherapy 4, 5 .
Several reports have delineated a two-step process that results in the thymic generation of T reg cells 6, 7 . First, CD4SP thymocytes must receive relatively strong signals through the T cell antigen receptor (TCR), a process that allows transcriptional changes and increases in cell-surface expression of the high-affinity α-chain of the interleukin 2 (IL-2) receptor (CD25). Signaling by IL-2 via the signal transducer STAT5 is needed for complete development, which leads to induction of the T reg cell-defining transcription factor Foxp3. Although many studies have documented the requirements for strong TCR signals and IL-2 in T reg cell development [6] [7] [8] [9] , less is known about how these requirements are integrated. In particular, it is not known whether TCR ligands and IL-2 signals must be spatially linked to efficiently promote T reg cell development.
Studies of mice expressing rearranged, T reg cell-biased Tcra and Tcrb transgenes have revealed that T reg cell development is most efficient when only a small fraction of thymocytes express a particular TCR 10, 11 . In addition, limiting intraclonal competition leads to increased TCR signaling, which suggests that binding of the TCR to self peptide and major histocompatibility complex (MHC) can be a limiting factor when the frequency of thymocytes expressing a defined TCR is high 8 . Whether competition for IL-2 is also involved in establishing the size of the thymic T reg cell niche remains unknown.
Understanding the nature of the T reg cell niche is complicated by the fact that the thymic source of IL-2 remains unknown. In the periphery, T cells are the most abundant producers of IL-2, which has led to the suggestion that thymocytes may provide IL-2 to developing T reg cells. However, there are also reports that dendritic cells (DCs) can produce limited quantities of IL-2 in certain settings 12, 13 . Given indications that IL-2 concentrations are limiting for the thymic development of T reg cells [14] [15] [16] , identifying the sources of IL-2 in the thymus, as well as the factors that govern its availability to developing T reg cells, is key to defining the thymic T reg cell niche.
We have developed an experimental system in which thymocytes expressing a transgene encoding a defined MHC class II-specific TCR are introduced into a thymic tissue slice in the presence of their cognate antigen, which leads to a synchronized wave of T reg cell development. Using this system, we found that antigen-bearing DCs provided a local source of IL-2 to promote T reg cell development. We also found that existing T reg cells within the thymic environment inhibited new T reg cell development by limiting the supply of available IL-2. Our data suggest a model in which localized antigen presentation and IL-2 supply, along with competition for IL-2 from existing T reg cells, establish a tightly controlled but flexible negative feedback loop to maintain balanced production of T reg cells.
RESULTS T reg cell development in thymic tissue slices
Published reports have suggested that the thymic development of T reg cells is limited by the frequency of thymocytes specific for a particular 6 3 6 VOLUME 16 NUMBER 6 JUNE 2015 nature immunology A r t i c l e s self antigen and competition for the relevant self antigen [8] [9] [10] [11] 17 . To further investigate the limited niche for T reg cell development, we used a thymic slice model in which a small number of thymocytes bearing a defined MHC class II-restricted TCR (OT-II) develop in the presence of their cognate antigen (ovalbumin (OVA)). We used OT-II thymocytes from a recombination activating gene 2-deficient (Rag2 −/− ) background (called simply 'OT-II thymocytes' here) as a starting population with no detectable T reg cells; this provided a sensitive and synchronized system with which to track the development of new T reg cells in response to antigen encounter within the thymic slice. We gave wild-type mice an intravenous injection of 2 mg of soluble OVA protein, an approach that has been shown to induce antigen-specific thymic T reg cells in vivo 18, 19 . One hour after injection, we killed the mice, prepared thymic slices and introduced OT-II thymocytes into the slices. Flow cytometry revealed upregulation of CD25 expression on OT-II CD4SP thymocytes after 1 d of culture and the appearance of Foxp3 + CD25 + cells after 3 d (Supplementary  Fig. 1) , consistent with the timing of T reg cell development inferred from intrathymic transfer studies 7 .
T reg cells can develop from immature T cells in the thymus or can be derived from mature peripheral CD4 + T cells by TCR stimulation in the presence of the immunosuppressive cytokine transforming growth factor-β (TGF-β) 20 . To confirm that the thymic slice system recapitulated normal thymic T reg cell development, we compared the ability of OT-II thymocytes versus that of mature OT-II T cells to give rise to T reg cells upon introduction into thymic slices ( Supplementary  Fig. 2a) . Mature OT-II T cells showed some upregulation of CD25 expression, but no Foxp3 expression, upon culture in thymic slices prepared from mice that had previously been given an injection of OVA protein (Supplementary Fig. 2a ). The addition of TGF-β led to a small population of Foxp3 + cells; however, these cells had low expression of the thymus-derived T reg cell marker neuropilin-1 (refs. 21, 22) (Supplementary Fig. 2a) . In contrast, OT-II thymocytes cultured in thymic slices gave rise to Foxp3 + cells without the addition of TGF-β, and they also expressed neuropilin-1 ( Supplementary  Fig. 2a) . Neither OT-II thymocytes nor mature T cells gave rise to T reg cells when stimulated with OVA-loaded DCs in vitro without thymic slices and without the addition of TGF-β ( Supplementary  Fig. 2b) . Moreover, depletion of mature CD4SP cells from OT-II thymocyte samples before their addition to thymic slices delayed, but did not prevent, the development of T reg cells (Supplementary Fig. 2c,d and data not shown), which indicated that Foxp3 + cells arose from a relatively immature thymocyte population. These data indicated that the development of Foxp3 + cells from OT-II thymocytes on thymic slices was distinct from the in vitro development of T reg cells from mature conventional CD4 + T cells and suggested that the combination of the thymic environment and the developmental stage of the precursor cells was important for the development of thymus-derived T reg cells.
To probe the role of antigen availability in T reg cell development, we varied the antigen dose and delivery method. Injection of a high dose of soluble OVA led to the development of OT-II T reg cells after 3 d on thymic slices, whereas injection of one tenth the dose of OVA led to reduced but detectable development of T reg cells (Fig. 1a) . 
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We observed no expression of CD25 or Foxp3 when we cultured OT-II thymocytes in slices from control mice given an injection of PBS (Fig. 1a) . As an alternative mode of antigen delivery, we used mice in which a membrane-associated form of OVA is transgenically expressed in medullary thymic epithelial cells and the pancreas (RIP-mOVA mice) 23 . Again, we observed a substantial population of CD25 + Foxp3 + OT-II thymocytes after 3 d of culture on thymic slices from RIP-mOVA mice (Fig. 1b) . As a third approach to introducing antigen, we incubated bone marrow-derived DCs with OVA protein and then introduced them into thymic slices containing OT-II thymocytes by overlaying them on top of the slice and allowing them to migrate into the tissue. Again we observed new T reg cell development, which increased with antigen dose (Fig. 1c) . In contrast to published reports 10,11 , we did not observe any correlation between the frequency of OT-II thymocytes within thymic slices and the efficiency of T reg cell development (Supplementary Fig. 3 ), which indicated that the frequency of precursor cells was not a major limiting factor under our experimental conditions. To compare the efficiency of T reg cell development across various routes of antigen delivery, we calculated the number of Foxp3 + OT-II T reg cells as a ratio of the total CD4SP thymocytes in the thymic slice. The efficiency of T reg cell development varied with antigen abundance (Fig. 1d) , consistent with published studies 9, 18 . However, the proportion of OT-II thymocytes that developed into T reg cells was generally less than 20% ( Fig. 1 and Supplementary Fig. 3 ) and never exceeded the proportion of endogenous T reg cells within a slice (corresponding to 3-10% of total slice CD4SP thymocytes) (Fig. 1d) . We observed this upper limit on T reg cell development even under conditions in which the majority of thymocytes responded to antigen, as indicated by the induction of CD25 expression (Fig. 1c,d ). Together these results suggested there was a limited thymic niche for T reg cell development even when antigen encounter and the frequency of precursor cells were not limiting factors.
Existing thymic T reg cells reduce the niche size
The finding that the overall number of thymic T reg cells was limited to less than 10% of the total CD4SP population suggested that T reg cells themselves might inhibit new T reg cell development. To investigate whether existing T reg cells influence new T reg cell development, we prepared thymic slices from mice that lack thymic T reg cells (mice with transgenic expression of a TCR specific for MHC class II together with mutation of Rag2 (AND × Rag2 −/− mice)) 24 . For these experiments, we introduced antigen by adding 1 µM OVA peptide (amino acids 323-339) to thymic slices containing OT-II thymocytes. We consistently observed a greater number of CD25 + Foxp3 + OT-II thymocytes in T reg cell-deficient (AND × Rag2 −/− ) thymic slices than in T reg cell-sufficient (wild-type) thymic slices (Fig. 2a,b) . We also observed enhancement of new T reg cell development in T reg celldeficient slices when we used precursor cells with a different MHC class II-specific TCR (2D2 × Rag2 −/− ) ( Supplementary Fig. 4a ,b) and when we used thymic slices from a different T reg cell-deficient strain (mice with transgenic expression of a TCR specific for MHC class I together with mutation of Rag2 (F5 × Rag2 −/− )) ( Supplementary  Fig. 4c,d) . Finally, T reg cell development in thymic slices from mice with transgenic TCR expression (AND × Rag2 −/− ) was inhibited by the addition of sorted thymic T reg cells to thymic slices (Fig. 2c,d) , which indicated that the lack of T reg cells, rather than other abnormal features of the thymic environment with transgenic TCR expression, was responsible for the enhanced T reg cell development. Combined these results provided evidence that existing thymic T reg cells limited the development of new T reg cells.
T reg cells do not interfere with peptide recognition T reg cells can reduce the stimulatory capacity of antigen-presenting cells (APCs) in the periphery, which suggests that thymic T reg cells might inhibit new T reg cell development by interfering with the ability of thymic APCs to present agonist self peptides 25 . To test this idea we assessed expression of the transcription factor Nur77, which provides a quantitative 'readout' of accumulated TCR signal strength 8 . The addition of OVA peptide to T reg cell-sufficient or T reg cell-deficient thymic slices resulted in similar expression of CD25 and Nur77 by OT-II thymocytes at 6 h ( Fig. 3a-c) , which suggested that existing T reg cells did not influence the initial TCR signal received by OT-II thymocytes. As a measure of accumulated TCR signal, we also assessed Nur77 expression within the OT-II T reg cell population that developed after 3 d in the presence or absence of existing T reg cells (Fig. 3d) . Consistent with published reports 8 , endogenous T reg cells from the thymic slice had slightly higher expression of Nur77 than did conventional CD4SP thymocytes (Fig. 3e) , and newly developed OT-II T reg cells had slightly higher expression of Nur77 than did endogenous T reg cells in the slice ( A r t i c l e s T reg cell population was similar for OT-II T reg cells that developed on T reg cell-sufficient (wild-type) slices and those that developed on T reg cell-deficient slices (Fig. 3e) . Together these results provided evidence that existing T reg cells were able to limit new T reg cell development without altering TCR signaling.
IL-2 availability influences the size of the T reg cell niche
In addition to requiring agonist self peptide, developing T reg cells need IL-2 to fully mature and express Foxp3 (refs. 6,7). To confirm the requirement for IL-2 in the thymic slice model, we used OVA protein-injected Il2 −/− mice as a source of thymic slices for T reg cell development. Half the number of OT-II thymocytes developed into T reg cells after 3 d on Il2 −/− slices relative to the number that developed on wild-type slices (Fig. 4a,b) . This reduction in OT-II T reg cell development was mirrored by the reduction in endogenous T reg cells from Il2 −/− slices, which confirmed the requirement for IL-2 for efficient thymic T reg cell development and maturation [14] [15] [16] . Notably, these data indicated that any IL-2 produced by added OT-II thymocytes was not able to fully compensate for the lack of IL-2 from the thymic environment, which highlighted the importance of IL-2 sources within the thymic slice itself. To determine whether IL-2 is a limiting factor for T reg cell development, we assessed the effect of the addition of IL-2. We used complexes of IL-2 and antibody to IL-2 (anti-IL-2), which display an extended half-life compared with that of IL-2 alone 26, 27 . The addition of IL2-anti-IL-2 complexes to thymic slices doubled the number of OT-II T reg cells that developed per slice in both the wild-type environment and the Il2 −/− environment (Fig. 4a,b) , which suggested that the availability of IL-2 was a limiting factor for expansion of the T reg cell niche. The addition of IL-2-anti-IL-2 complexes boosted the number of endogenous T reg cells within the slice (Fig. 4c) , which indicated that IL-2 was also limiting for T reg cells in the steady-state thymus. It is noteworthy that the addition of IL-2-anti-IL-2 complexes did not fully restore the number of T reg cells in Il2 −/− slices (Fig. 4b,c) , which suggested a requirement for a localized source of IL-2 for efficient T reg cell development or an altered thymic environment in Il2 −/− mice. Together these data indicated that IL-2 was both necessary and limiting for thymic T reg cell development within thymic slices.
Existing T reg cells limit the availability of IL-2 and/or IL-15
On the basis of reports that peripheral T reg cells can limit T cell effector function via absorption of IL-2 from the environment 28,29 , we considered that thymic T reg cells might inhibit new T reg cell development by limiting the available cytokine supplies. To detect available IL-2 and IL-15 (a related cytokine that also supports T reg cell development 14 ), we used the mouse cell line CTLL2, which is dependent on IL-2 or IL-15 (ref. 30) . CTLL2 cells proliferated when added to wild-type thymic slices (Fig. 5a) , consistent with the presence of available IL-2 and IL-15 within the tissue. Moreover, CTLL2 cells cultured on T reg cell-deficient (AND × Rag2 −/− ) slices showed enhanced survival at day 2 and more robust proliferation on day 4 (Fig. 5a,b) , which suggested greater abundance of available IL-2 and/or IL-15 in the T reg cell-deficient environment than in the T reg cell-sufficient environment. 
A r t i c l e s
To further probe the role of T reg cells in limiting IL-2 availability within the thymus, we added IL-2-anti-IL-2 complexes to thymic slices prepared from wild-type and T reg cell-deficient (AND × Rag2 −/− ) mice that had been given an injection of OVA protein. The addition of IL-2-anti-IL-2 complexes to T reg cell-sufficient wild-type slices increased the frequency and absolute numbers of OT-II T reg cells twofold (Fig. 5c,d) . Moreover, the addition of IL-2-anti-IL-2 complexes to T reg cell-deficient slices enhanced T reg cell development fourfold. These experiments demonstrated that while existing T reg cells within the thymus limited IL-2 availability, IL-2 remained a limiting factor for new T reg cell development even in the absence of existing T reg cells. These data also indicated that existing T reg cells were able to inhibit new T reg cell development even in the presence of large quantities of IL-2, which suggested tight feedback control of IL-2 availability.
APCs provide a local source of IL-2 for T reg cell development We next investigated the cellular source of IL-2 for thymic T reg cell development. While T cells are typically considered the main producers of IL-2, our observation that wild-type OT-II thymocytes were unable to restore T reg cell development in Il2 −/− thymic slices suggested that thymocytes might not provide an important source of IL-2 for T reg cell development. Published reports have suggested that DCs are able to express small amounts of IL-2 in certain settings 12, 13, 31 .
To investigate whether antigen-bearing DCs might provide a local source of IL-2, we compared T reg cell development promoted by wild-type antigen-loaded DCs versus that promoted by Il2 −/− antigenloaded DCs. DCs derived in vitro from the bone marrow of young, asymptomatic Il2 −/− mice expressed cell surface markers similar to those expressed by wild-type bone marrow-derived DCs (data not shown). Moreover, when we incubated Il2 −/− DCs with OVA protein and introduced the cells into thymic slices, they led to normal upregulation of the expression of TCR-activation markers on OT-II thymocytes ( Supplementary Fig. 5a-d) , which indicated that they had a normal capacity to process and present antigen. However, OT-II T reg cell development promoted by OVA-loaded Il2 −/− DCs was only half that promoted by OVA-loaded wild-type DCs (Fig. 6a-c) . As expected, there was no change in overall number of endogenous T reg cells in the slices, regardless of whether the added DCs were IL-2 deficient or IL-2 sufficient (Fig. 6d) , which indicated that the addition of wild-type DCs did not globally increase the abundance of IL-2 in the environment. The addition of IL-2-sufficient OVA-loaded DCs to IL-2-deficient thymic slices increased T reg cell development over that observed when both DC and slices were deficient in IL-2 ( Supplementary Fig. 6 ). Together these results indicated that the 
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A r t i c l e s antigen-bearing DCs were able to provide a relevant local source of IL-2 to promote T reg cell development. Our data, together with published evidence that thymic DCs are important as APCs for T reg cell induction 18, 19, 32, 33 , suggested that thymic DCs might express IL-2. Although we were unable to detect IL-2 protein in the thymus (data not shown), we were able to measure Il2 mRNA from thymus by a sensitive quantitative RT-PCR assay (Fig. 6e) . We found that purified thymic DCs expressed approximately fivefold more Il2 mRNA than did total, dissociated cells from the thymus, whereas the adherent thymic stromal cell compartment was depleted of Il2 mRNA compared with Il2 mRNA in the total thymus (Fig. 6e, left) . While thymic DCs expressed more IL-2 than did thymocytes as a whole, it is noteworthy that depletion of CD11c + cells from dissociated thymus samples did not significantly reduce the overall amount of Il2 mRNA in the samples (Fig. 6e, left) . These data indicated that DCs were not the sole source of IL-2 within the thymus. Notably, while Il2 mRNA was also detectable over background in bone marrow-derived DCs, Il2 expression was ~250-fold lower in these cells than in thymic DCs (Fig. 6e, right) . This indicated that very low levels of IL-2 had a potent effect on T reg cell development when the IL-2 was expressed by the same cell that also displayed the antigenic peptide. Together our data support a model in which limited APC-derived IL-2, together with competition by existing T reg cells, defines the size of the thymic niche for new T reg cell development (Supplementary Fig. 6c ).
DISCUSSION
The limited capacity of the thymus to support T reg cell development might be related to the dual requirements for TCR ligands and IL-2, but how these signals work together to define the size of the T reg cell niche is not well understood. Here we demonstrated that existing T reg cells within the thymus exerted control over the size of the thymic T reg cell niche by limiting the supply of available IL-2. We also showed that IL-2 produced by antigen-bearing cells, including DCs, promoted T reg cell development. Combined, our data suggest that the thymic niche for T reg cell development includes thymic APCs that can supply both a TCR ligand and IL-2 and indicate that existing T reg cells exert tight control over this niche by limiting available IL-2.
T cells are known to be the main producers of IL-2; thus, the indications that DCs provided an important source of IL-2 for T reg cell development were rather unexpected. Moreover, the finding that DCderived IL-2 promoted the development of antigen-specific T reg cells in an IL-2-sufficient environment, and without boosting global T reg cell production, indicated that IL-2 is most effective when supplied by the same cell that is presenting the agonist peptide-MHC ligand. The physical linkage between antigen presentation and IL-2 supply might facilitate T reg cell development by increasing the probability that thymocytes will receive signals from both the TCR and IL-2. Moreover, the recognition of peptide-MHC by the TCR might help to position thymocytes near the source of IL-2 and allow them to compete more effectively for limiting supplies of the cytokine. Finally, our data suggest that thymic APCs that are able to provide both antigen and IL-2 might be particularly adept at supporting T reg cell development, which potentially explains the ability of certain thymic APCs to 'preferentially' induce T reg cell development rather than negative selection 32 .
The role of IL-2 in thymic T reg cell development has been revealed by genetic approaches 16, 31, 34 , but thymic concentrations of IL-2 are low, and the relevant cellular sources of the cytokine have remained unknown. Our data revealed that small amounts of IL-2 had a potent effect on T reg cell development when the IL-2 was produced by the same cell that presented self antigen. Evidence that DCs have an important role as APCs for T reg cell development 18, 32, 33, 35 , together with our data showing that thymic DCs expressed IL-2, suggests that thymic DCs are an important source of IL-2. However, our data do not rule out the possibility that other cell types might provide IL-2 in some settings. Of particular interest are medullary thymic epithelial cells (mTECs), which can also serve as APCs to drive T reg cell development 36, 37 . Notably, mTECs express very little mRNA encoding IL-2 but express substantially more mRNA encoding the related cytokine IL-15 and its presenting receptor IL-15Rα 38 , which suggests that mTECs might present IL-15 along with antigen to promote T reg cell development. Alternatively, the close contact and cell-to-cell transfer between mTECs and DCs 39 might allow these cell types to contribute both self antigen and IL-2 to the same niche for T reg cell development.
Our data also indicated the involvement of existing thymic T reg cells in a negative feedback loop that limited the size of the thymic T reg cell niche via competition for IL-2. Modeling studies indicate that competition by mature T reg cells for peripheral sources of IL-2 is a local phenomenon, with most paracrine absorption occurring within 10-200 µm of the IL-2 source 40 . That, together with our evidence showing that access to IL-2 was localized to the peptide-bearing DCs, suggests that competition between T reg cells and their precursors for IL-2 might also occur locally, perhaps during interactions with the same APC. Notably, IL-2 signaling also directly induces expression of the high-affinity α-chain of the IL-2 receptor (CD25), which further increases the competition for IL-2 binding [40] [41] [42] . Tight feedback control on the availability of IL-2 might help to explain why manipulations designed to increase IL-2 availability (such as adding IL-2 or eliminating existing T reg cells) led to only modest (twofold) increase in new T reg cell development. As precursors of T reg cells are exposed to free IL-2, they rapidly become more efficient competitors for IL-2 and exert additional negative feedback on the niche.
Published studies of mice expressing T reg cell-biased TCRs have suggested that clonal competition for binding self antigen limits T reg cell development when the frequency of thymocytes specific for a particular self antigen is high [8] [9] [10] . In contrast, we found little effect of precursor frequency on the efficiency of T reg cell development, and T reg cell development remained relatively inefficient, even when antigen abundance was high and the majority of OT-II thymocytes upregulated CD25 expression in response to antigen. We propose that the factors that limit access to the T reg cell niche might vary depending on the abundance of self antigen and the frequency of thymocytes specific for the self antigen. Under conditions of low precursor frequency and abundant self antigen, IL-2 becomes the main limiting factor for T reg cell development. On the other hand, if the abundance of self antigen is very low and/or the frequency of thymocytes specific for self antigen is high, competition for antigen recognition may become a limiting factor. In addition, while our study focused on the competition among T reg cells for IL-2, existing T reg cells may also inhibit new T reg cell development by competing for additional factors, such as B7 (the ligand for the coreceptor CD28) and/or ligands for the tumor-necrosis factor receptor superfamily 43, 44 .
Together our data support a model in which IL-2-producing APCs within the thymus, in conjunction with the number of existing T reg cells within the vicinity of the IL-2 source, determine the size of the T reg cell niche. As thymocytes interact with APCs, mature into T reg cells and provide negative feedback by absorbing local supplies of IL-2, the niche remains balanced. Eventually, in a system with thymocyte egress intact, mature T reg cells would cycle out of the niche, which would ease the competition for IL-2 and allow further rounds npg of T reg cell development. Efforts to increase T reg cell production for therapeutic purposes should take into account the complex layering of feedback that exists to maintain proper niche output. In particular, linking IL-2 production and self-antigen presentation, as well as continuous removal of newly developing IL-2 competitors, should provide effective strategies for maximizing thymic T reg cell development.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Mice. All mice were bred and maintained under pathogen-free conditions within facilities approved by the American Association of Laboratory Animal Care at the University of California, Berkeley. The internal review board and the Animal Use and Care Committee at the University of California, Berkeley, approved all procedures. C57BL/6, B6.SJL-Ptprca Pepcb/BoyJ (CD45.1), 2D2 TCR transgenic, AND, B6.129P2-Il2tm1Hor/J(IL2−/−), C57BL/6-Tg(Ins2-TFRC/OVA)296Wehi/WehiJ (RIP-mOVA) and Foxp3-GFP mice (expressing green fluorescent protein (GFP) under the control of the Foxp3 promoter) were from Jackson Laboratories. 2D2 × Rag2 −/− mice were generated by crossing of 2D2 mice with Rag2 −/− mice from Taconic. OT-II × Rag2 −/− mice were from Taconic. F5 × Rag2 −/− mice have been described 45 . Endotoxin-free soluble OVA was from Invivogen, and injections were performed intravenously, followed by killing of the mice 1 h later.
Thymocytes, T reg cell isolation and CTLL2 culture. Thymocytes were isolated from OT-II × Rag2 −/− thymuses or 2D2 × Rag2 −/− thymuses via mechanical disruption. Cells were filtered through nylon mesh and were resuspended in complete DMEM (containing 10% FBS, non-essential amino acids, sodium pyruvate, l-glutamine and 2-mercaptoethanol) for overlay onto thymic slices. OT-II thymocytes were distinguished from slice-resident thymocytes through use of the congenic markers CD45.1 and CD45.2, used in conjunction with staining for the specific TCRα-chain corresponding to the transgene expressed by the mice. Thymic T reg cells were isolated from Foxp3-GFP mice. Thymic cell suspensions were depleted of CD8 + single-positive thymocytes and CD4 + CD8 + double-positive thymocytes through the use of anti-CD8 microbeads (Miltenyi), then the remaining CD4SP thymocytes were sorted by flow cytometry on the basis of GFP expression to generate >95% pure thymic T reg cells. Sorted thymic T reg cells were resuspended in DMEM complete medium for use with thymic slices. As a bioassay for available IL-2 and IL-15, we used the CTLL2 cell line, a transformed IL-2-and/or IL-15-dependent cell line derived from C57BL/6 mice. CTLL2 cells (a gift from the N. Shastri laboratory; verified free of mycoplasma before use) were cultured in complete RPMI medium (containing 10% FBS, non-essential amino acids, sodium pyruvate, l-glutamine and 2-mercaptoethanol) along with 50 U/ml IL-2 until they were washed and overlaid on thymic slices. 1 × 10 6 CTLL2 cells per slice were added and were allowed to migrate into slices for 4 h before samples were washed.
Thymic slices. Thymic slice preparation has been described 46,47 . Whole thymic lobes isolated from mice were embedded in 4% agarose with a low melting point and were cut into sections 400 µm in thickness with a vibratome. Slices were cultured in 0.4-µm tissue-culture inserts set in DMEM complete medium. 1 × 10 6 thymocytes resuspended in 10 µl of DMEM were overlaid on the slice and were allowed to migrate into thymic slices for 2-4 h, followed by gentle pipetting for the removal of thymocytes that did not migrate into the slice. Under these conditions, 3 × 10 3 to 1 × 10 4 thymocyte enter the slice and migrate to their expected locations on the basis of their stage of development following chemokine gradients and other guidance cues within the tissue slice, as reported 48, 49 . The medium was changed daily during the 3-day culture period. For experiments with sorted T reg cells, OT-II thymocytes were first overlaid, followed by incubation for 4 h, followed by washing and the addition of 1 × 10 5 Foxp3-GFP T reg cells, and further incubation for 4 h. Thymic slices derived from each thymus were randomized by order of slicing after the slicing process, before use for experiments. To minimize the effect of variation in the size of thymic slice and the proportion of cortex and medulla, we used adjacent thymic slices for experimental comparisons. In some cases, we normalized T reg cell numbers to the number of total CD4SP cells (including slice-resident CD4SP cells), which allowed us to pool data from multiple experiments into a single graph. For experiments with mature OT-II T cells, T cells were isolated from the spleens of OT-II × Rag2 −/− mice, and 1 × 10 6 cells were overlaid onto thymic slices. In some cases, 5 ng/ml of TGF-β (Peprotech) was added along with the mature T cells to the slice.
Bone marrow-derived DC cultures. Bone marrow was flushed from femurs and tibias of mice, followed by lysis of red blood cells with ammonium chloride-potassium bicarbonate buffer. Cells were resuspended in complete RPMI medium containing 10 ng/ml granulocyte-macrophage colony-stimulating factor and IL-4 (Peprotech), then were plated at a density of 0.5 × 10 6 cells per ml and were cultured for 7 d. Half of the medium was replaced on day 2, and full replacement of the medium with granulocyte-macrophage colonystimulating factor plus IL-4 was performed on day 5. Semi-adherent cells were isolated on day 7; after being washed, they were loaded for 30 min at 37 °C with soluble OVA protein (1 mg/ml; Invivogen). Cells were washed three times with Hank's balanced-salt solution and were overlaid onto thymic slices 4 h after addition of OT-II thymocytes. Cells were allowed to migrate into thymic slices for at least 4 h before excess cells that did not migrate into the slice were washed off. Bone marrow was collected from Il2 −/− mice when mice were <4 weeks of age, before the onset of pathology.
Quantitative PCR. Thymi from wild-type mice were dissociated by digestion for 1 h at 37 °C with collagenase (Sigma-Aldrich). Some of each sample was reserved for RNA isolation (whole-thymocyte samples), and the remainder was used for enrichment of DCs with MACS CD11c microbeads according to manufacturer's instructions (Miltenyi), followed by flow cytometry to achieve a final purity of a population of >85% CD11c + F4/80 − cells (thymic DC samples). The thymus sample after removal of CD11c + cells was also used for RNA isolation (CD11c-depleted samples). Cell samples were lysed in TRIzol (Life Technologies), and total RNA was prepared with an RNAeasy kit according to the manufacturer's instructions (Qiagen). Reverse transcription was performed with a Quatitect RT Kit (Qiagen), and cDNA was used for quantitative PCR with Taqman probes along with TaqMan Real-Time PCR master mix (Life Technologies). The PrimeTime probes Mm.PT.58.11478202 (for IL-2) and Mm.PT.39a.1 (for GAPDH), were synthesized by IDT. All reactions were run on an Applied Biosystems 7300 RT PCR machine. IL-2 expression data were normalized to those of the control gene encoding GAPDH (glyceraldehyde phosphate dehydrogenase) and are presented relative to background expression in Il2 −/− bone marrow-derived DCs, calculated by the change-in-cycling threshold (∆∆Ct) method. For Il2 −/− DCs, no Il2 signal was observed after 40 cycles of PCR; therefore, values reported are upper estimates (gray shading in figures) and were used to determine the lower limit of detection of the assay.
Flow cytometry. The following antibodies were used for cell-surface staining: Alexa Fluor 700-anti-mouse CD4 (GK1.5), allophycocyanin-eFluor 780-conjugated anti-CD8 (53-6.7), eFluor 450-or peridinin chlorophyll protein-cyanine 5.5-conjugated anti-CD25 (PC61.5), peridinin chlorophyll protein-eFluor 710-or allophycocyanin-conjugated anti-V 2 (B20.1), fluorescein isothiocyanate-conjugated anti-V α 3.2 (RR3-16), phycoerythrinindotricarbocyanine-conjugated anti-CD45.1 (A20) and fluorescein isothiocyanate-conjugated anti-CD45.2 (104) (all from eBioscience); Red Fluor 710-conjugated anti-CD4 (RM-5) and allophycocyanin-indotricarbocyanineconjugated anti-CD8 (53-6.7) (both from Tonbo Bioscience); and phycoerythrinconjugated anti-neuropilin-1 (3E12; Biolegend). Staining with the cellproliferation dye eFluor 450 was performed for 10 min at 37 °C with 2 µM eFluor 450 (eBioscience). For intracellular staining, allophycocyanin-or phycoerythrin-conjugated anti-Nur77 (12.14) and phycoerythrinconjugated anti-Foxp3 (FJK-16s) were used (both from eBioscience). Cells were first labeled with Ghost Dye viability dye (Tonbo), then were surface stained for 15 min on ice, followed by fixation and permeabilization according to manufacturer's instructions with the Foxp3 Transcription Factor staining buffer set (eBioscience). Flow cytometry was performed with a BD Fortessa or Fortessa X20 analyzer (BD Bioscience), and data were analyzed with FlowJo software (TreeStar).
Antibody complexes and peptides. Complexes of IL-2 and monoclonal antibody to IL-2 have been described 26, 27 . 1.5 µg recombinant IL-2 (eBioscience) was incubated for 30 min at 37 °C with 7.5 µg of functional-grade monoclonal antibody to IL-2 (JES6-1; eBioscience). Complexes were added directly to thymic slices (10 µl per slice) daily over the course of the experiment. Peptides of mouse myelin oligodendrocyte glycoprotein amino acids 35-55 and chicken OVA amino acids 323-339 were from Anaspec. Peptide was overlaid on thymic slices for 10-30 min after migration of thymocytes into the slice.
Statistics.
The unpaired Student's t-test and one-way ANOVA with Tukey's post-test were calculated with Prism software (GraphPad). A P value of <0.05 npg
